Reports

Vipshop's Q4 2024 revenue declined year-over-year, reflecting challenges in the retail market. However, the company maintained strong profitability, with net income exceeding $335 million. Operating margin contracted slightly due to higher marketing and administrative expenses.

• Total revenue for Q4 2024 was $4.55 billion, a 4.2% decrease year-over-year.
• Net income for Q4 2024 was $335.2 million, down from $407.4 million in Q4 2023.

U.S. Cellular reported a 3% decline in total operating revenue for Q4 2024, reaching $970 million. Net income dropped significantly to $5 million, and GAAP EPS fell to $0.05. The company highlighted improvements in postpaid and prepaid customer retention, but challenges in revenue growth remain.

• Total operating revenue declined 3% year-over-year to $970 million.
• Net income decreased to $5 million from $14 million in Q4 2023.

Balchem Corporation reported strong financial results for the fourth quarter of 2024, with record net sales of $240.0 million and adjusted EBITDA of $62.8 million. The company's GAAP net earnings increased by 26.0% compared to the prior year quarter, and free cash flow was $39.8 million.

• Net sales reached a record $240.0 million, a 4.9% increase year-over-year.
• GAAP net earnings increased by 26.0% to $33.6 million compared to the prior year quarter.

TXNM Energy posted $476.96M in revenue, reflecting a slight YoY decline, while net income improved to $15.71M. The company increased its capital investment plan by 26% to $7.8B and reaffirmed its commitment to grid expansion and reliability projects.

• Revenue decreased by 2.35% YoY to $476.96M.
• Net income improved to $15.71M from a loss of $50.23M last year.

TDS reported a 6% decline in total operating revenue for Q4 2024, reaching $1.24 billion. The company reported a net loss of $11 million, a significant improvement from the $523 million loss in Q4 2023. Operating income was positive at $37 million, driven by improved results from TDS Telecom, while UScellular faced continued challenges.

• Total operating revenue declined 6% year-over-year to $1.24 billion.
• Net loss improved significantly to $11 million from $523 million in Q4 2023.

Brady Corporation reported a 10.6% increase in sales, driven by acquisitions and organic growth. However, GAAP EPS declined by 7.8% while adjusted EPS increased by 7.5%. Net income also saw a year-over-year decline. The company raised the lower end of its adjusted EPS guidance for fiscal 2025.

• Sales increased by 10.6% to $356.7 million, with 2.6% organic growth.
• GAAP EPS decreased 7.8% to $0.83, while adjusted EPS increased 7.5% to $1.00.

Atmus Filtration Technologies reported Q4 2024 revenue of $407 million, reflecting a 1.8% increase year-over-year. Net income reached $40 million, with diluted EPS at $0.48 and adjusted EPS at $0.58. The company maintained a strong adjusted EBITDA margin of 19.1% and generated $28 million in adjusted free cash flow.

• Revenue increased by 1.8% year-over-year to $407 million.
• Net income rose to $40 million, with diluted EPS at $0.48.

Arbor Realty Trust reported a net income of $59.8 million, or $0.32 per diluted common share, and distributable earnings of $81.6 million, or $0.40 per diluted common share for the fourth quarter ended December 31, 2024. The company declared a quarterly cash dividend of $0.43 per share of common stock.

• GAAP net income of $0.32 and distributable earnings of $0.40 per diluted common share.
• Declared cash dividend on common stock of $0.43 per share.

Sunstone Hotel Investors reported Q4 2024 net income of $0.8 million, significantly down from $127.0 million in Q4 2023. Revenue declined slightly to $214.77 million, while adjusted EBITDAre decreased 12% to $48.1 million. Adjusted FFO per diluted share fell 15.8% to $0.16, reflecting weaker industry fundamentals and operational challenges.

• Net income fell to $0.8 million from $127.0 million in Q4 2023.
• Revenue declined to $214.77 million, down from $219.23 million last year.

Protagonist Therapeutics reported a significant increase in revenue and net income for Q4 2024, driven by a $165.0 million icotrokinra milestone payment. The company also announced positive topline results for its Phase 3 ICONIC-LEAD and ICONIC-TOTAL studies for icotrokinra and is anticipating key clinical trial results for rusfertide and icotrokinra in March 2025.

• Protagonist earned a $165.0 million icotrokinra milestone in Q4 2024, received in January 2025.
• PN-881, a potential best-in-class oral IL-17 receptor antagonist peptide, was nominated as a development candidate in Q4 2024.

Farmer Mac reported Q4 2024 net income of $50.8 million, up from $40.8 million in Q4 2023. Revenue increased to $93.37 million, reflecting higher net interest income. Diluted EPS grew 24% year-over-year to $4.63, while core EPS slightly declined to $3.97. The company also announced a 7% increase in its quarterly dividend.

• Net income increased 24.5% to $50.8 million.
• Revenue rose to $93.37 million, driven by higher net interest income.

Hawaiian Electric Industries (HEI) reported a net loss of $68 million, or $0.40 per share, for the fourth quarter of 2024, compared to a net income of $49 million, or $0.44 per share, for the same period in 2023. The results reflect higher O&M expenses, offset by increased revenues and gains on property sales. Core income from continuing operations was $35 million, slightly below the $37 million reported in Q4 2023.

• Net loss for Q4 2024 was $68 million, or $0.40 per share, compared to a net income of $49 million, or $0.44 per share, in Q4 2023.
• Core income from continuing operations was $35 million for Q4 2024, compared to $37 million in Q4 2023.

Uniti Group reported consolidated revenues of $293.3 million for Q4 2024, with a net income of $21.6 million and Adjusted EBITDA of $239.5 million. The company's core recurring strategic fiber revenue grew by approximately 5% in 2024, and consolidated bookings were up 40% compared to the same period last year.

• Consolidated revenues for the fourth quarter of 2024 were $293.3 million.
• Net income for the fourth quarter of 2024 was $21.6 million.

Oil States International, Inc. reported a net income of $15.2 million, or $0.24 per share, and Adjusted EBITDA of $18.7 million for Q4 2024 on revenues of $164.6 million. The results included a gain from a facility sale, offset by restructuring charges. Revenues decreased sequentially due to lower U.S. land-based activity and the exit of certain service lines.

• Net income of $15.2 million, or $0.24 per share, was reported, including a facility sale gain partially offset by restructuring charges.
• Adjusted net income of $5.5 million, or $0.09 per share, was reported, excluding the facility sale gain and restructuring charges.